Stocklytics Platform
Asset logo for symbol MEDP
Medpace Holdings
MEDP76
$365.70arrow_drop_down0.94%-$3.47
High Quality
Asset logo for symbol MEDP
MEDP76

$365.70

arrow_drop_down0.94%

Performance History

Chart placeholder
Key Stats
Open$367.98
Prev. Close$369.17
EPS10.63
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range359.44
370.51
52 Week Range227.21
459.76
Ratios
EPS10.63

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Medpace Holdings (MEDP)

Medpace Holdings Inc. (MEDP) is a global contract research organization (CRO) that provides fully integrated clinical research services, including designing and conducting all phases of clinical trials for pharmaceutical, biotechnology, and medical device companies. The company's services also include regulatory support, project management, data management, statistical analysis, and medical writing. Medpace has a strong track record of successfully delivering high-quality clinical trials on time and within budget, which has enabled it to build long-term relationships with its clients.
Medpace's business model is based on a highly specialized and experienced team of clinical research professionals who have deep therapeutic and regulatory knowledge. The company's employees have an average of 20 years of industry experience, and many hold advanced degrees in medicine, pharmacy, or life sciences. This expertise allows Medpace to provide customized solutions to its clients and to navigate the complex regulatory landscape effectively.
Sector
Healthcare
Industry
Diagnostics & Research
CEO
Dr. August James Troendle M.D.
Headquarters
Cincinnati
Employees
5400
Exchange
NASDAQ
add Medpace Holdings  to watchlist

Keep an eye on Medpace Holdings

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Medpace Holdings 's (MEDP) price per share?

The current price per share for Medpace Holdings (MEDP) is $365.7. The stock has seen a price change of -$3.48 recently, indicating a -0.94% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Medpace Holdings (MEDP)?

For Medpace Holdings (MEDP), the 52-week high is $459.77, which is 25.72% from the current price. The 52-week low is $227.21, the current price is 60.95% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Medpace Holdings (MEDP) a growth stock?

Medpace Holdings (MEDP) has shown an average price growth of 0.41% over the past three years. It has received a score of 88 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Medpace Holdings as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Medpace Holdings (MEDP) stock price performance year to date (YTD)?

As of the latest data, Medpace Holdings (MEDP) has a year-to-date price change of 19.67%. Over the past month, the stock has experienced a price change of -7.58%. Over the last three months, the change has been -9.49%. Over the past six months, the figure is -11.52%. Looking at a longer horizon, the five-year price change stands at 330.84%.
help

Is Medpace Holdings (MEDP) a profitable company?

Medpace Holdings (MEDP) has a net income of $282.81M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 27.81% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 19.91% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.89B, with a revenue growth rate of 29.17%, providing insight into the company's sales performance and growth. The gross profit is $524.5M. Operating income is noted at $336.82M. Furthermore, the EBITDA is $410.12M.
help

What is the market capitalization of Medpace Holdings (MEDP)?

Medpace Holdings (MEDP) has a market capitalization of $11.34B. The average daily trading volume is 366.7K, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media